Skip to Content

Maci

Active Substance: autologous cultured chondrocytes
Common Name: matrix-applied characterised autologous cultured chondrocytes
ATC Code: M09AX02
Marketing Authorisation Holder: Vericel Denmark ApS
Active Substance: autologous cultured chondrocytes
Status: Suspended
Authorisation Date: 2013-06-27
Therapeutic Area: Fractures, Cartilage
Pharmacotherapeutic Group: Other medicines for disorders of the musculoskeletal system

Therapeutic Indication

Repair of symptomatic cartilage defects of the knee.

The marketing authorisation for Maci has been suspended at the recommendation of the  Agency's Committee for Medicinal Products for Human Use (CHMP).

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide